(Health-NewsWire.Net, September 05, 2019 ) Market Overview: The Genome Editing Market size is expected to grow at a CAGR of 16.40% during the forecast period (2018-2025).
Genome editing is a scientific way of modifying DNA of many organisms such as plants, bacteria, and animals.
Market Dynamics: The global genome editing market growth is driven by several factors such as growing government initiatives in genome editing field and raising awareness of the genomics. However, a high cost of genomic equipment is restraining the growth of the market at its full potential.
Market Segmentation: The Genome Editing market is segmented, by Technology into: CRISPR/Cas TALEN Zinc Finger Nuclease (ZFN) Others
By application, the market is segmented into: Genetic Engineering (Plant, Animal) Cell Line Engineering Curing genetic diseases Drug Discovery and Development Others
Based on end-user, the market is segmented into: Government & Academic Research Institutes Biotech & Pharmaceutical Companies Contract Research Organizations
Geographical Analysis: Geographically, the market is segmented into: North America South America Europe Asia-Pacific The Middle East and Africa
Competitve Analysis: Key Players are: Alere Inc Thermo Fisher Scientific Inc. Horizon Discovery Group PLC Merck KGaA Origene Technologies Inc. Sangamo Biosciences Inc. Transposagen Biopharmaceuticals Inc. Others
About Us: DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information: Sai Kiran Sales Manager at Data M Intelligence Email: info@datamintelligence.com Tel: +1 877 441 4866 Website: www.datamintelligence.com